A group of cationic antimicrobial peptides and its preparation method and application
A technology of medicinal salts and amino acids, applied in the field of medicine, can solve the problems of high antibacterial activity and low hemolytic activity, and achieve a significant bactericidal effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] Embodiment 1: Preparation and purification of AMP-1
[0046] Sequence: Phe-Leu-Phe-Leu-Phe-Leu-Lys-Lys-Arg-Lys-Lys-Arg-Lys-His-NH 2 (SEQ ID NO: 1)
[0047] (1) Materials and reagents
[0048] Rink Amide MBHA resin, substitution value 0.41mmol / g.
[0049] The amino acids to be protected are Fmoc-L-Arg(Pbf)-OH, Fmoc-L-Leu-OH, Fmoc-L-Lys(Boc)-OH, Fmoc-L-Phe-OH and Fmoc-L-His (Trt)-OH.
[0050] Reagents: HOBt, DIC, DMF, piperidine.
[0051] (2) Instrument
[0052] PSI300 peptide synthesizer, Waters600 semi-preparative high performance liquid chromatography, magnetic stirrer.
[0053] (3) Operation steps (take 0.25mmol as an example)
[0054] a. Solid-phase chemical synthesis of peptides
[0055] Weigh 0.61g of Rink Amide MBHA resin, put it in the reactor of the peptide synthesizer, add 10mL of DMF, soak for 2h, then add 15mL of 20% PIP / DMF solution, mix for 30min to remove the amino protecting agent, and wash the resin 7 times with DMF , then add 619.8mg Fmoc-L-His...
Embodiment 2
[0070] Embodiment 2: Preparation and purification of AMP-2 and AMP-3
[0071] Sequence: Phe-Leu-Leu-Phe-Leu-Leu-Lys-Lys-Arg-Lys-Lys-Arg-Lys-His-NH 2 (SEQ ID NO: 2)
[0072] Trp-Trp-Trp-Phe-Trp-Trp-Lys-Lys-Arg-Lys-Lys-Arg-Lys-His-NH 2 (SEQ ID NO: 3)
[0073] (1) Materials and reagents
[0074] Rink Amide MBHA resin, substitution value 0.41mmol / g.
[0075] Required protected amino acids Fmoc-L-Arg(Pbf)-OH, Fmoc-L-Leu-OH, Fmoc-L-Lys(Boc)-OH, Fmoc-L-Phe-OH, Fmoc-L-Trp( Boc)-OH and Fmoc-L-His(Trt)-OH.
[0076] Reagents: HOBt, DIC, DMF, piperidine.
[0077] (2) Instrument
[0078] PSI300 peptide synthesizer, Waters600 semi-preparative high performance liquid chromatography, magnetic stirrer.
[0079] (3) Operation steps (take 0.25mmol as an example)
[0080] AMP-2 and AMP-3 were prepared and purified in a manner similar to the steps a-c in Example 1, and the fractions with a purity greater than 99% were collected and then concentrated to dryness at 50°C under reduced pressu...
Embodiment 3
[0082] Embodiment 3: Preparation and purification of cationic antimicrobial peptides in table 2
[0083] The cationic antimicrobial peptides in Table 4 were prepared and purified in a similar manner to Example 1, but the cationic antimicrobial peptides involved in the present invention are not limited thereto.
[0084] Table 4 Cationic Antimicrobial Peptides
[0085]
[0086]
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 